An Observational Study on Treatment Compliance by Children Treated With Growth Hormone

Withdrawn

• Conditions: Growth Hormone Deficiency in Children; Growth Hormone Disorder
• Interventions: Behavioral: No treatment given

• Registration Number: NCT01068639
• Lead Sponsor: Novo Nordisk A/S

Brief Summary

This study is conducted in Europe. This observational study aims at evaluating compliance with growth hormone treatment in children and identifying factors influencing compliance.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design

Study Timeline

• Study Start: 2010-02
• Study First Submitted: 2010-02-12
• Study First Submitted QC: 2010-02-12
• Study First Posted: 2010-02-15
• Primary Completion: 2010-04
• Study Completion: 2010-04
• Status Verified: 2014-06
• Last Update Submitted: 2014-06-25
• Last Update Posted: 2014-06-26

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Child treated for at least one year with growth hormone any growth hormone product
• Followed by the participating paediatrician for at least 1 year.

Read More

Exclusion Criteria

• Refusal to participate
• Child and/or parent unable to give consent or fill out the questionnaires
• Child participating in a therapeutic trial

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
A	No treatment given	-

Primary Outcome Measures

Name	Time	Method
Average number of injections omitted during the previous month	measured over the past 2 months (retrospective data collection)